Medsol is an AI and DML company focusing on point of care solutions for medical imaging.  SMART – a diagnosis method-based software algorithm which can identify and correctly term the type of breast cancer depicted on ultrasound. It is an AI based breast cancer diagnostic solution. The solution enables effective diagnosis of cancer with the ability to determine the type of breast cancer upon diagnosis. Medsol AI offers the health practitioners diagnostic input for quicker turnaround time, treatment and surgical intervention. Breast AI offers on site differential diagnosis for patients in rural settings, referral time reduced from 6 months to one week. The product is 65% cheaper than its competitors. Medsol signed an MOU with Astrazeneca African Cluster for further roll out product in SA and African markets.